TIDMBARC
RNS Number : 4841Z
Barclays PLC
21 May 2021
Publication of Pricing Supplements
The following pricing supplements are available for viewing:
1. Pricing Supplement in relation to Barclays PLC's issue of
A$150,000,000 2.064 per cent. Fixed-to-Floating Rate Debt
Instruments due May 2027 (the "Pricing Supplement 1");
2. Pricing Supplement in relation to Barclays PLC's issue of
A$250,000,000 Floating Rate Debt Instruments due May 2027 (the
"Pricing Supplement 2"); and
3. Pricing Supplement in relation to Barclays PLC's issue of
A$200,000,000 3.382 per cent. Fixed-to-Floating Rate Debt
Instruments due May 2032 (the "Pricing Supplement 3") (together the
"Pricing Supplements"),
each issued under the Barclays PLC A$10,000,000,000 Debt
Issuance Programme.
Please read the disclaimer below "Disclaimer - Intended
Addressees" before attempting to access this service, as your right
to do so is conditional upon complying with the requirements set
out below.
To view Pricing Supplement 1, please paste the following URL
into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/4841Z_1-2021-5-21.pdf
To view Pricing Supplement 2, please paste the following URL
into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/4841Z_2-2021-5-21.pdf
To view Pricing Supplement 3, please paste the following URL
into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/4841Z_3-2021-5-21.pdf
Copies of the above documents have been submitted to the
National Storage Mechanism and will shortly be available for
inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information, please contact:
Barclays Treasury
1 Churchill Place
Canary Wharf
London E14 5HP
DISCLAIMER - INTENDED ADDRESSEES
IMPORTANT : You must read the following before continuing: The
following applies to the Pricing Supplements available by clicking
on the links above, and you are therefore advised to read this
carefully before reading, accessing or making any other use of the
Pricing Supplements. In accessing the Pricing Supplements, you
agree to be bound by the following terms and conditions, including
any modifications to them, any time you receive any information
from us as a result of such access.
The Pricing Supplements referred to above must be read in
conjunction with the information memorandum dated 7 May 2021 (the
"IM").
THE PRICING SUPPLEMENTS MAY NOT BE FORWARDED OR DISTRIBUTED
OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY
MANNER WHATSOEVER. THE PRICING SUPPLEMENTS MAY ONLY BE DISTRIBUTED
OUTSIDE THE UNITED STATES TO PERSONS THAT ARE NOT U.S. PERSONS AS
DEFINED IN, AND IN RELIANCE ON, REGULATION S UNDER THE U.S.
SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). ANY
FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE PRICING SUPPLEMENTS
IN WHOLE OR IN PART IS PROHIBITED. FAILURE TO COMPLY WITH THIS
NOTICE MAY RESULT IN A VIOLATION OF THE SECURITIES ACT OR THE
APPLICABLE LAWS OF OTHER JURISDICTIONS.
NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF
SECURITIES FOR SALE IN ANY JURISDICTION. ANY DEBT INSTRUMENTS
ISSUED OR TO BE ISSUED PURSUANT TO THE PRICING SUPPLEMENTS AND THE
IM HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE SECURITIES
ACT OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR
OTHER JURISDICTION. ANY DEBT INSTRUMENTS ISSUED OR TO BE ISSUED
PURSUANT TO THE PRICING SUPPLEMENTS AND THE IM MAY NOT BE OFFERED,
SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN AN OFFSHORE
TRANSACTION TO A PERSON THAT IS NOT A U.S. PERSON IN ACCORDANCE
WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES
ACT.
Barclays PLC is not a bank or authorised deposit-taking
institution which is authorised under the Banking Act 1959
(Commonwealth of Australia) ("Australian Banking Act"). The Debt
Instruments are not obligations of the Australian Government or any
other government and, in particular, are not guaranteed by the
Commonwealth of Australia. Barclays PLC is not supervised by the
Australian Prudential Regulation Authority. An investment in any
Debt Instrument issued by Barclays PLC will not be covered by the
depositor protection provisions in section 13A of the Australian
Banking Act and will not be covered by the Australian Government's
bank deposit guarantee (also commonly referred to as the Financial
Claims Scheme). Debt Instruments that are offered for issue or sale
or transferred in, or into, Australia are offered only in
circumstances that would not require disclosure to investors under
Parts 6D.2 or 7.9 of the Corporations Act 2001 of Australia and
issued and transferred in compliance with the terms of the
exemption from compliance with section 66 of the Australian Banking
Act that is available to Barclays PLC.
Please note that the information contained in the Pricing
Supplements and the IM referred to above may be addressed to and/or
targeted at persons who are residents of particular countries
(specified in the Pricing Supplements and/or the IM) only and is
not intended for use and should not be relied upon by any person
outside these countries and/or to whom the offer contained in the
Pricing Supplements and/or the IM is not addressed. Prior to
relying on the information contained in the Pricing Supplements
and/or the IM you must ascertain from the Pricing Supplements and
the IM whether or not you are part of the intended addressees of
the information contained therein.
Confirmation of your Representation : In order to be eligible to
view the Pricing Supplements or make an investment decision with
respect to any Debt Instruments issued or to be issued pursuant to
the Pricing Supplements, you must be a person other than a U.S.
person (within the meaning of Regulation S under the Securities
Act). By accessing the Pricing Supplements, you shall be deemed to
have represented that you and any customers you represent are not
U.S. persons, and that you consent to delivery of the Pricing
Supplements via electronic publication.
You are reminded that the Pricing Supplements have been made
available to you on the basis that you are a person into whose
possession the Pricing Supplements may be lawfully delivered in
accordance with the laws of the jurisdiction in which you are
located and you may not, nor are you authorised to, deliver the
Pricing Supplements to any other person.
The Pricing Supplements do not constitute, and may not be used
in connection with, an offer or solicitation in any place where
offers or solicitations are not permitted by law. If a jurisdiction
requires that the offering be made by a licensed broker or dealer
and the underwriters or any affiliate of the underwriters is a
licensed broker or dealer in that jurisdiction, the offering shall
be deemed to be made by the underwriters or such affiliate on
behalf of the issuer in such jurisdiction. Under no circumstances
shall the Pricing Supplements constitute an offer to sell, or the
solicitation of an offer to buy, nor shall there be any sale of any
Debt Instruments issued or to be issued pursuant to the Pricing
Supplements, in any jurisdiction in which such offer, solicitation
or sale would be unlawful.
The Pricing Supplements have been made available to you in an
electronic form. You are reminded that documents transmitted via
this medium may be altered or changed during the process of
electronic transmission and consequently none of the issuer, its
advisers nor any person who controls any of them nor any director,
officer, employee nor agent of it or affiliate of any such person
accepts any liability or responsibility whatsoever in respect of
any difference between the Pricing Supplements made available to
you in electronic format and the hard copy versions available to
you on request from the issuer.
Your right to access this service is conditional upon complying
with the above requirement.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PSPBXGDUCXDDGBB
(END) Dow Jones Newswires
May 21, 2021 10:05 ET (14:05 GMT)
Barclays (LSE:BARC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Barclays (LSE:BARC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
